AVBP

AVBP

USD

ArriVent BioPharma Inc. Common Stock

$22.030+0.370 (1.708%)

Real-time Price

Healthcare
Biotechnology
United States

Price Chart

Loading Chart...

Key Metrics

Market Metrics
Company Fundamentals
Trading Stats

Market Metrics

Open

$21.660

High

$22.320

Low

$20.938

Volume

0.17M

Company Fundamentals

Market Cap

834.5M

Industry

Biotechnology

Country

United States

Trading Stats

Avg Volume

0.32M

Exchange

NGM

Currency

USD

52-Week Range

Low $15.47Current $22.030High $36.37

Related News

Analyst Upgrades

Clear Street Initiates Coverage On ArriVent BioPharma with Buy Rating, Announces Price Target of $32

Clear Street analyst Kaveri Pohlman initiates coverage on ArriVent BioPharma with a Buy rating and announces Price Target of $32.

View more
Clear Street Initiates Coverage On ArriVent BioPharma with Buy Rating, Announces Price Target of $32
Analyst Upgrades

Oppenheimer Maintains Outperform on ArriVent BioPharma, Raises Price Target to $44

Oppenheimer analyst Jeff Jones maintains ArriVent BioPharma with a Outperform and raises the price target from $39 to $44.

View more
Oppenheimer Maintains Outperform on ArriVent BioPharma, Raises Price Target to $44
Analyst Upgrades

Guggenheim Reiterates Buy on ArriVent BioPharma, Maintains $45 Price Target

Guggenheim analyst Michael Schmidt reiterates ArriVent BioPharma with a Buy and maintains $45 price target.

View more
Guggenheim Reiterates Buy on ArriVent BioPharma, Maintains $45 Price Target